| Log Type | Authored on | Log Node | Authored by |
|---|---|---|---|
| Newsletter opened | Anonym | ||
| Newsletter opened | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonym | |
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter subscribed | Anonym | ||
| User created | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter subscribed | Anonym | ||
| User created | Anonym | ||
| Newsletter opened | Dr. Mattingly discute abordagens durante a pandemia | Anonym | |
| Newsletter opened | Convite Lundbeck Webinar Internacional | Anonym | |
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter subscribed | Anonym | ||
| User created | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| User created | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym |
| Log Type | Authored on | Log Node | Authored by |
|---|---|---|---|
| Newsletter opened | Anonym | ||
| Newsletter opened | Novos medicamentos têm como alvo a CGRP e seus receptores | Anonym | |
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter subscribed | Anonym | ||
| User created | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter subscribed | Anonym | ||
| User created | Anonym | ||
| Newsletter opened | Dr. Mattingly discute abordagens durante a pandemia | Anonym | |
| Newsletter opened | Convite Lundbeck Webinar Internacional | Anonym | |
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter subscribed | Anonym | ||
| User created | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym | ||
| User created | Anonym | ||
| Newsletter opened | Anonym | ||
| Newsletter opened | Anonym |